Self-assembling peptide nanotubes with antiviral activity against hepatitis C virus

Chemistry and Biology

Volumn 18, Issue 11, 2011, Pages 1453-1462

  Montero, Ana ^a   Gastaminza, Pablo ^a   Law, Mansun ^a   Cheng, Guofeng ^a   Chisari, Francis V ^a   Ghadiri, M Reza ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; PEPTIDE NANOTUBE; VIRUS RNA;

AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; DRUG EFFECT; HEPATITIS C VIRUS; HUMAN; PEPTIDE LIBRARY; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; CELL LINE, TUMOR; HEPACIVIRUS; HUMANS; NANOTUBES, PEPTIDE; PEPTIDE LIBRARY; RNA, VIRAL; STRUCTURE-ACTIVITY RELATIONSHIP; VIRUS REPLICATION;

EID: 82255163991     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2011.08.017     Document Type: Article

References (61)

1. M.J. Alter The epidemiology of acute and chronic hepatitis C Clin. Liver Dis. 1 1997 559 568 vi-vii
2. M.J. Alter Hepatitis C virus infection in the United States J. Hepatol. 31 Suppl 1 1999 88 91 (Pubitemid 30002698)
3. R. Bartenschlager, and V. Lohmann Replication of hepatitis C virus J. Gen. Virol. 81 2000 1631 1648 (Pubitemid 30427068)
4. B. Bartosch, J. Dubuisson, and F.L. Cosset Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes J. Exp. Med. 197 2003 633 642 (Pubitemid 36314658)
5. G. Bernhardt, H. Reile, H. Birnböck, T. Spruss, and H. Schönenberger Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity J. Cancer Res. Clin. Oncol. 118 1992 35 43
6. E. Blanchard, S. Belouzard, L. Goueslain, T. Wakita, J. Dubuisson, C. Wychowski, and Y. Rouillé Hepatitis C virus entry depends on clathrin-mediated endocytosis J. Virol. 80 2006 6964 6972 (Pubitemid 44025195)
7. K.J. Blight, A.A. Kolykhalov, and C.M. Rice Efficient initiation of HCV RNA replication in cell culture Science 290 2000 1972 1974
8. D.T. Bong, T.D. Clark, J.R. Granja, and M.R. Ghadiri Self-Assembling Organic Nanotubes Angew. Chem. Int. Ed. Engl. 40 2001 988 1011
9. M.E. Burlone, and A. Budkowska Hepatitis C virus cell entry: role of lipoproteins and cellular receptors J. Gen. Virol. 90 2009 1055 1070
10. S.S. Carroll, and D.B. Olsen Nucleoside analog inhibitors of hepatitis C virus replication Infect. Disord. Drug Targets 6 2006 17 29 (Pubitemid 43796633)
11. K.S. Chang, J. Jiang, Z. Cai, and G. Luo Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture J. Virol. 81 2007 13783 13793 (Pubitemid 350247871)
12. G. Cheng, A. Montero, P. Gastaminza, C. Whitten-Bauer, S.F. Wieland, M. Isogawa, B. Fredericksen, S. Selvarajah, P.A. Gallay, M.R. Ghadiri, and F.V. Chisari A virocidal amphipathic alpha-helical peptide that inhibits hepatitis C virus infection in vitro Proc. Natl. Acad. Sci. USA 105 2008 3088 3093 (Pubitemid 351723672)
13. T.D. Clark, L.K. Buehler, and M.R. Ghadiri Self-assembling cyclic β3-peptide nanotubes as artificial transmembrane ion channels J. Am. Chem. Soc. 120 1998 651 656 (Pubitemid 28081942)
14. V. Dartois, J. Sanchez-Quesada, E. Cabezas, E. Chi, C. Dubbelde, C. Dunn, J. Granja, C. Gritzen, D. Weinberger, M.R. Ghadiri, and T.R. Parr Jr. Systemic antibacterial activity of novel synthetic cyclic peptides Antimicrob. Agents Chemother. 49 2005 3302 3310 (Pubitemid 41060575)
15. M. Dreux, P. Gastaminza, S.F. Wieland, and F.V. Chisari The autophagy machinery is required to initiate hepatitis C virus replication Proc. Natl. Acad. Sci. USA 106 2009 14046 14051
16. S. Fernandez-Lopez, H.S. Kim, E.C. Choi, M. Delgado, J.R. Granja, A. Khasanov, K. Kraehenbuehl, G. Long, D.A. Weinberger, K.M. Wilcoxen, and M.R. Ghadiri Antibacterial agents based on the cyclic D,L-alpha-peptide architecture Nature 412 2001 452 455 (Pubitemid 32702711)
17. J.T. Fletcher, J.A. Finlay, M.E. Callow, J.A. Callow, and M.R. Ghadiri A combinatorial approach to the discovery of biocidal six-residue cyclic D,L-α-peptides against the bacteria methicillin-resistant Staphylococcus aureus (MRSA) and E. coli and the biofouling algae Ulva linza and Navicula perminuta Chemistry 13 2007 4008 4013 (Pubitemid 46925610)
18. M. Flint, C. Logvinoff, C.M. Rice, and J.A. McKeating Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins J. Virol. 78 2004 6875 6882 (Pubitemid 38781525)
19. P. Gastaminza, S.B. Kapadia, and F.V. Chisari Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles J. Virol. 80 2006 11074 11081 (Pubitemid 44706548)
20. P. Gastaminza, C. Whitten-Bauer, and F.V. Chisari Unbiased probing of the entire hepatitis C virus lifecycle identifies clinical compounds that target multiple aspects of the infection Proc. Natl. Acad. Sci. USA 107 2010 291 296
21. P. Gastaminza, G. Cheng, S. Wieland, J. Zhong, W. Liao, and F.V. Chisari Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion J. Virol. 82 2008 2120 2129 (Pubitemid 351293514)
22. P. Gastaminza, S.M. Pitram, M. Dreux, L.B. Krasnova, C. Whitten-Bauer, J. Dong, J. Chung, V.V. Fokin, K.B. Sharpless, and F.V. Chisari Antiviral stilbene 1,2-diamines prevent initiation of hepatitis C virus RNA replication at the outset of infection J. Virol. 85 2011 5513 5523
23. M.A. Gelman, and J.S. Glenn Mixing the right hepatitis C inhibitor cocktail Trends Mol. Med. 2010 [Epub ahead of print] PMID: 21106440
24. M.R. Ghadiri, J.R. Granja, and L.K. Buehler Artificial transmembrane ion channels from self-assembling peptide nanotubes Nature 369 1994 301 304
25. M.R. Ghadiri, J.R. Granja, R.A. Milligan, D.E. McRee, and N. Khazanovich Self-assembling organic nanotubes based on a cyclic peptide architecture Nature 366 1993 324 327 (Pubitemid 23349358)
26. M.R. Ghadiri, K. Kobayashi, J.R. Granja, R.K. Chadha, and D.E. McRee The structural and thermodynamic basis for the formation of self-assembled peptide nanotubes Angew. Chem. Int. Ed. Engl. 34 1995 93 95
27. J.R. Granja, and M.R. Ghadiri Channel-mediated transport of glucose across lipid bilayers J. Am. Chem. Soc. 116 1994 10785 10786
28. W. Hao, K.J. Herlihy, N.J. Zhang, S.A. Fuhrman, C. Doan, A.K. Patick, and R. Duggal Development of a novel dicistronic reporter-selectable hepatitis C virus replicon suitable for high-throughput inhibitor screening Antimicrob. Agents Chemother. 51 2007 95 102 (Pubitemid 46047693)
29. J.D. Hartgerink, J.R. Granja, R.A. Milligan, and M.R. Ghadiri Self-assembling peptide nanotubes J. Am. Chem. Soc. 118 1996 43 50
30. J.H. Hoofnagle Course and outcome of hepatitis C Hepatology 365 Suppl 1 2002 S21 S29 (Pubitemid 35253460)
31. W.S. Horne, C.M. Wiethoff, C. Cui, K.M. Wilcoxen, M. Amorin, M.R. Ghadiri, and G.R. Nemerow Antiviral cyclic D,L-alpha-peptides: targeting a general biochemical pathway in virus infections Bioorg. Med. Chem. 13 2005 5145 5153 (Pubitemid 41039973)
32. M. Hsu, J. Zhang, M. Flint, C. Logvinoff, C. Cheng-Mayer, C.M. Rice, and J.A. McKeating Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles Proc. Natl. Acad. Sci. USA 100 2003 7271 7276 (Pubitemid 36706428)
33. H. Huang, F. Sun, D.M. Owen, W. Li, Y. Chen, M. Gale Jr. , and J. Ye Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins Proc. Natl. Acad. Sci. USA 104 2007 5848 5853 (Pubitemid 47175622)
34. J. Jiang, and G. Luo Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles J. Virol. 83 2009 12680 12691
35. S.B. Kapadia, and F.V. Chisari Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids Proc. Natl. Acad. Sci. USA 102 2005 2561 2566 (Pubitemid 40279416)
36. T. Kato, A. Furusaka, M. Miyamoto, T. Date, K. Yasui, J. Hiramoto, K. Nagayama, T. Tanaka, and T. Wakita Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient J. Med. Virol. 64 2001 334 339 (Pubitemid 32565130)
37. H.S. Kim, J.D. Hartgerink, and M.R. Ghadiri Oriented self-assembly of cyclic peptide nanotubes in lipid membranes J. Am. Chem. Soc. 120 1998 4417 4424 (Pubitemid 28261202)
38. S.S. Kim, L.F. Peng, W. Lin, W.H. Choe, N. Sakamoto, N. Kato, M. Ikeda, S.L. Schreiber, and R.T. Chung A cell-based, high-throughput screen for small molecule regulators of hepatitis C virus replication Gastroenterology 132 2007 311 320 (Pubitemid 46108745)
39. K. Kobayashi, J.R. Granja, and M.R. Ghadiri Beta-sheet peptide architecture: measuring the relative stability of parallel vs. antiparallel beta-sheets Angew. Chem. Int. Ed. Engl. 34 1995 95 98
40. G. Koutsoudakis, A. Kaul, E. Steinmann, S. Kallis, V. Lohmann, T. Pietschmann, and R. Bartenschlager Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses J. Virol. 80 2006 5308 5320
41. D. Lamarre, P.C. Anderson, M. Bailey, P. Beaulieu, G. Bolger, P. Bonneau, M. Bös, D.R. Cameron, M. Cartier, and M.G. Cordingley An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus Nature 426 2003 186 189 (Pubitemid 37442587)
42. T.J. Liang, B. Rehermann, L.B. Seeff, and J.H. Hoofnagle Pathogenesis, natural history, treatment, and prevention of hepatitis C Ann. Intern. Med. 132 2000 296 305 (Pubitemid 30106261)
43. B.D. Lindenbach, M.J. Evans, A.J. Syder, B. Wölk, T.L. Tellinghuisen, C.C. Liu, T. Maruyama, R.O. Hynes, D.R. Burton, J.A. McKeating, and C.M. Rice Complete replication of hepatitis C virus in cell culture Science 309 2005 623 626 (Pubitemid 41033648)
44. V. Lohmann, F. Körner, J. Koch, U. Herian, L. Theilmann, and R. Bartenschlager Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line Science 285 1999 110 113 (Pubitemid 29307577)
45. T. Matsumura, Z. Hu, T. Kato, M. Dreux, Y.Y. Zhang, M. Imamura, N. Hiraga, J.M. Juteau, F.L. Cosset, and K. Chayama Amphipathic DNA polymers inhibit hepatitis C virus infection by blocking viral entry Gastroenterology 137 2009 673 681
46. D. Moradpour, F. Penin, and C.M. Rice Replication of hepatitis C virus Nat. Rev. Microbiol. 5 2007 453 463 (Pubitemid 46780082)
47. L. Motiei, S. Rahimipour, D.A. Thayer, C.H. Wong, and M.R. Ghadiri Antibacterial cyclic D,L-alpha-glycopeptides Chem. Commun. (Camb.) 25 2009 3693 3695
48. C.L. Murray, C.T. Jones, and C.M. Rice Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis Nat. Rev. Microbiol. 6 2008 699 708
49. I.M. Pedersen, G. Cheng, S. Wieland, S. Volinia, C.M. Croce, F.V. Chisari, and M. David Interferon modulation of cellular microRNAs as an antiviral mechanism Nature 449 2007 919 922 (Pubitemid 47598616)
50. T. Pietschmann, A. Kaul, G. Koutsoudakis, A. Shavinskaya, S. Kallis, E. Steinmann, K. Abid, F. Negro, M. Dreux, F.L. Cosset, and R. Bartenschlager Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras Proc. Natl. Acad. Sci. USA 103 2006 7408 7413 (Pubitemid 43727846)
51. N.W. Roehm, G.H. Rodgers, S.M. Hatfield, and A.L. Glasebrook An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT J. Immunol. Methods 142 1991 257 265
52. A.E. Smith, and A. Helenius How viruses enter animal cells Science 304 2004 237 242 (Pubitemid 38452168)
53. A.I. Su, J.P. Pezacki, L. Wodicka, A.D. Brideau, L. Supekova, R. Thimme, S. Wieland, J. Bukh, R.H. Purcell, P.G. Schultz, and F.V. Chisari Genomic analysis of the host response to hepatitis C virus infection Proc. Natl. Acad. Sci. USA 99 2002 15669 15674 (Pubitemid 35403989)
54. D.M. Tscherne, C.T. Jones, M.J. Evans, B.D. Lindenbach, J.A. McKeating, and C.M. Rice Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry J. Virol. 80 2006 1734 1741 (Pubitemid 43228714)
55. C. Voisset, M. Lavie, F. Helle, A.O. De Beeck, A. Bilheu, J. Bertrand-Michel, F. Terce, L. Cocquerel, C. Wychowski, and N. Vu-Dac Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry Cell Microbiol. 10 2008 606 617 (Pubitemid 351194090)
56. T. Wakita, T. Pietschmann, T. Kato, T. Date, M. Miyamoto, Z. Zhao, K. Murthy, A. Habermann, H.G. Kräusslich, and M. Mizokami Production of infectious hepatitis C virus in tissue culture from a cloned viral genome Nat. Med. 11 2005 791 796 (Pubitemid 41021213)
57. Wilcoxen, K.M. (2002). Investigations into the Biomimetic Synthesis. Structural Determination and Therapeutic Development of Antimicrobial Peptides. PhD thesis, The Scripps Research Institute, La Jolla, California.
58. M.C. Wolf, A.N. Freiberg, T. Zhang, Z. Akyol-Ataman, A. Grock, P.W. Hong, J. Li, N.F. Watson, A.Q. Fang, and H.C. Aguilar A broad-spectrum antiviral targeting entry of enveloped viruses Proc. Natl. Acad. Sci. USA 107 2010 3157 3162
59. J. Ye, C. Wang, R. Sumpter Jr. , M.S. Brown, J.L. Goldstein, and M. Gale Jr. Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation Proc. Natl. Acad. Sci. USA 100 2003 15865 15870 (Pubitemid 38021081)
60. J. Zhong, P. Gastaminza, J. Chung, Z. Stamataki, M. Isogawa, G. Cheng, J.A. McKeating, and F.V. Chisari Persistent hepatitis C virus infection in vitro: coevolution of virus and host J. Virol. 80 2006 11082 11093 (Pubitemid 44706549)
61. J. Zhong, P. Gastaminza, G. Cheng, S. Kapadia, T. Kato, D.R. Burton, S.F. Wieland, S.L. Uprichard, T. Wakita, and F.V. Chisari Robust hepatitis C virus infection in vitro Proc. Natl. Acad. Sci. USA 102 2005 9294 9299 (Pubitemid 40923557)